Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Search for FDA Guidance Documents

Search for FDA Guidance Documents

                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents Home
          Regulatory Information
          Search for FDA Guidance Documents
          The Meaning of "Spouse" and "Family" in FDA's Regulations after the Supreme Court's Ruling in United States v. Windsor: Questions and AnswersSearch for FDA Guidance Documents GUIDANCE DOCUMENT
	The Meaning of "Spouse" and "Family" in FDA's Regulations after the Supreme Court's Ruling in United States v. Windsor: Questions and Answers
					Guidance for Industry, Consumers, and FDA Staff
		
		April 2014


	Download the  Final Guidance Document 

    Final

	  
	  
	Share
    Post
    Linkedin

    Email
    PrintDocket Number:
		    FDA-2014-D-0261
	    	    		    Issued by:
		    Guidance Issuing Office
          Office of the Commissioner, Office of Policy, Legislation, and International Affairs, Office of Policy


Table of Contents

I. Introduction

II. Questions and Answers

***Q1: How does the Supreme Court's United States v. Windsor decision affect FDA's regulations?***

Q2: Do you have to live or intend to live in a state in which same-sex marriage is legal for FDA’s regulations using the terms "spouse" or "family" to apply to you?

Q3: Which FDA regulations are affected by the Windsor decision?

Reference Information

To obtain copies of this guidanceI. Introduction

On June 26, 2013, in United States v. Windsor, 133 S.Ct. 2675, the Supreme Court struck down as unconstitutional section 3 of the Defense of Marriage Act (DOMA). Using a question and answer format, we, FDA, are informing the public of our current thinking about the meaning of "spouse" or "family" in our regulations in light of this ruling.

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.

II. Questions and Answers

**Q1: How does the Supreme Court’s United States v. Windsor decision affect FDA’s regulations?**

A1: Section 3 of DOMA defined "marriage" and "spouse" to exclude same-sex spouses. Because the Supreme Court ruled this section unconstitutional, FDA need no longer exclude same-sex spouses from the definition of these terms. Consistent with the Department of Health and Human Service (HHS) policy, FDA will interpret the terms "spouse" and "family" in its regulations to include same-sex spouses.

**Q2: Do you have to live or intend to live in a state in which same-sex marriage is legal for FDA’s regulations using the terms "spouse" or family" to apply to you?**

A2: No. We interpret "spouse" or "family" in our regulations to include any individuals of the same sex who are lawfully married and whose marriage is valid in the state, territory or foreign nation where it took place. These terms also include same-sex spouses whose marriages are valid in the state, territory, or foreign nation where they live. This policy is consistent with a post-Windsor policy of treating same-sex marriages on the same terms as opposite-sex marriages to the greatest extent reasonably possible. By broadening the coverage of "spouse" and "family" to include same-sex spouses, it also advances the underlying goals of FDA’s regulations. For example, requiring clinical investigators to disclose the financial interests and arrangements of their same-sex spouses (see discussion of FDA Financial Disclosure by Clinical Investigators below) better ensures that conflicts of interests do not arise.

**Q3: Which FDA regulations are affected by the Windsor decision?**

A3: Because they use the terms "spouse" or "family," six parts of FDA’s regulations are affected by the Windsor decision. Consistent with this decision and HHS policy, FDA now reads these terms to include same-sex spouses. The affected regulations are as follows:

FDA Freedom of Information Act (FOIA) program (21 CFR 20.44 (b)). A "family member," including a same-sex spouse, of an individual subject to an imminent threat may request expedited processing of a FOIA request.
	FDA Human Subject Protection (21 CFR 50.3 (l), (m), 50.24(a)(6), (a)(7)(v), (b)). "Family member" means, among other things, "spouse," "brothers, sisters, and spouses of brothers and sisters," and "any individual related by . . . affinity whose close association with the subject is the equivalent of a family relationship." An exception from the requirement to obtain informed consent of research subjects exists if obtaining informed consent is not feasible and a legally authorized representative is not reasonably available. If feasible, an investigator must attempt to contact a subject’s family member, which can include a same-sex spouse, to ask whether he or she objects to the subject’s participation in the clinical investigation. Additionally, if a subject remains incapacitated and a subject’s legally authorized representative is not reasonably available, an Institutional Review Board (IRB) shall ensure that there is a procedure to inform a family member, which can include a same-sex spouse, that he or she may discontinue the subject’s participation at any time without penalty or loss of benefits to which the subject is otherwise entitled. If such a family member is told about the clinical investigation and the subject’s condition improves, the subject is also to be informed as soon as feasible. If a subject is entered into a clinical investigation with waived consent and the subject dies before a legally authorized representative or family member, which can include a same-sex spouse, can be contacted, information about the clinical investigation is to be provided to the subject’s legally authorized representative or such family member, if feasible.
	FDA Financial Disclosure by Clinical Investigators (21 CFR 54.2(d)). Part 54 of FDA’s regulations requires disclosure of certain types of financial interests and arrangements involving a "clinical investigator" and defines "clinical investigator" to include the investigator’s "spouse." Consistent with the Windsor decision and HHS policy, FDA now interprets Part 54 to require disclosure of certain financial interests and arrangements involving any clinical investigator’s same-sex spouse.
	Institutional Review Board for FDA-regulated Research (21 CFR 56.107(d)). Each IRB must have at least one member who is not otherwise affiliated with the institution and is not part of the "immediate family," now including a same-sex spouse, of a person affiliated with the institution.
	Qualified Expert Panels for Indexing New Animal Drugs (21 CFR 516.141(g)(2), (g)(3)). Information required to be submitted to FDA and factors considered to prevent conflicts of interest in members of these expert panels include information relating to "spouses," including same-sex spouses.
	Mammography Quality Standards Program (21 CFR 900.2(k)). Mammography facilities must have systems for collecting and resolving consumer complaints. "Consumer" includes a patient or patient representative—for example, a "family member," including a same-sex spouse.Reference Information

Additional copies of this guidance are available from the Office of Policy, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, or by calling 301-796-4830,


 
	Submit Comments
	   		  			    		Submit Comments Online
					You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
						If unable to submit comments online, please mail written comments to:
						Dockets Management
							Food and Drug Administration
							5630 Fishers Lane, Rm 1061
							Rockville, MD 20852
						All written comments should be identified with this document's docket number: FDA-2014-D-0261.

                                                                                  Content current as of:
      03/26/2018
         
                  
Regulated Product(s)
		 Biologics
			  			     			  			     Cosmetics
			     			  			     Dietary Supplements
			     			  			     Drugs
			     			  			     Food & Beverages
			     			  			     Medical Devices
			     			  			     Radiation-Emitting Products
			     			  			     Tobacco
			     			  						              
			
			
			
			
			
						  Food & Color AdditivesTopic(s)
			  Administrative / ProceduralSearch for FDA Guidance Documents

        Search for FDA Guidance Documents

          
                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop